Chikungunya Vaccine Candidate Induces Strong Immune Response
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine
COVID-19 Plus Heart Attack Tied to Higher Mortality and Complications
Furthermore, significant racial disparities seen in acute myocardial outcomes during the pandemic
Letermovir Noninferior for CMV Prophylaxis in Kidney Recipients
Findings in cytomegalovirus-seronegative kidney transplant recipients who receive organ from cytomegalovirus-seropositive donors
Feds Urge States to Slow Down on Dropping People From Medicaid
States are now reevaluating Medicaid eligibility after having been prohibited from dropping people during the early years of the pandemic
Outpatient Metformin Treatment Reduces Incidence of Long COVID
Beneficial effect of metformin consistent across subgroups
Decreases in Mpox Vaccination Shortfall Needed in Minorities
To achieve equitable progression in vaccination, decreases in shortfalls needed for Black, AI/AN persons
Third Dose of COVID-19 Vaccine Seems Safe for Young Children
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine
Clinical Language Model Can Predict Readmission
Model trained on clinical notes that accurately predict three clinical and two operational tasks
U.S. Life Expectancy Disadvantage Began in 1950s, Worsened Over Time
Fifty-six countries from six continents surpassed U.S. life expectancy during 1933 to 2021
FDA Panel Backs RSV Vaccine for Infants, Some Toddlers
Monoclonal antibody shot would protect against RSV in infants born during or entering their first RSV season
